Heights Capital Management »

Rani Therapeutics Hldgs shares owned by Heights Capital Management

Quarter-by-quarter ownership of Rani Therapeutics Hldgs (RANI) shares owned by Heights Capital Management from 13F filings

Historical chart of Heights Capital Management investment in Rani Therapeutics Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Rani Therapeutics Hldgs held by Heights Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rani Therapeutics Hldgs by Heights Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $711k 935k 0.76

More positions owned by Heights Capital Management

Flutter Entmt SHS (FLUT)
Amc Entmt Hldgs Cl A New (AMC)
Meiragtx Holdings (MGTX)
Taysha Gene Therapies Com Shs (TSHA)
Starlink Ai Acquisition Corp Unit 99/99/9999
Ch4 Natural Solutions Corp Ord Shs Cl A
Jackson Acquisition Co Ii Com Shs Cl A (JACS)
Jab Acquisition Corp I Unit 06/05/2031
Drugs Made In Amer Acqutn Ord Shs (DMAA)
Toyo Ord Sh (TOYO)
Snow Rothschild Acquisition Unit 05/22/2031
Gores Holdings Xi Unit 06/24/2031
Iron Dome Acquisition I Corp Unit 02/27/2031
Alpex Acquisition Corp Unit 06/05/2031
Pono Cap Four Cl A Ord Shs

View all positions for Heights Capital Management

Top funds holding Rani Therapeutics Hldgs

Samsara BioCapital
RA Capital Management
AWM Investment Company
Vanguard Capital Management
SymBiosis Capital Partners
Longaeva Partners
Polar Securities
Siren
Heights Capital Management
Geode Capital Management
Citadel Advisors
Marshall Wace
Jane Street
Nan Fung Group Holdings
Vanguard Fiduciary Trust

View all funds holding Rani Therapeutics Hldgs